Results 131 to 140 of about 27,891 (280)

Montelukast and Churg-Strauss syndrome

open access: yesSwiss Medical Weekly, 2004
The association of leukotriene receptor antagonists and Churg-Strauss Syndrome (CSS) has been recognised for several years. However, whether these drugs have a direct pathogenic role remains controversial. The present case describes an asthmatic patient, who developed severe obstructive symptoms and progressive heart failure after two sequential ...
David, Conen   +5 more
openaire   +3 more sources

Treating asthma: is there a place for leukotriene receptor antagonists? [PDF]

open access: yes, 2005
SummaryAsthma is a chronic disorder, characterized by airway hyperresponsiveness (AHR), airway inflammation and airway remodelling. Evidence has been provided for a relationship between pathophysiology, airway inflammation and remodelling.
Björn Sarrazin   +8 more
core   +3 more sources

Attenuation of acute systemic inflammatory response after valve surgery

open access: yesJournal of Contemporary Medical Sciences, 2017
Objective This study highlights the protective effects of montelukast on myocardial ischemic reperfusion injury induced by cardiopulmonary bypass during valve replacement surgery.
Najah R. Hadi   +8 more
doaj  

The influence of montelukast on the autonomic nervous system activity in rats with cyclophosphamide-induced hemorrhagic cystitis

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2015
The complex pathogenesis of cyclophosphamide-induced hemorrhagic cystitis involves arachidonic acid-derived inflammatory mediators, among them leukotrienes. Montelukast, a leukotriene receptor antagonist, is reported to exert an alleviatory effect in the
Dobrek Lukasz   +3 more
doaj   +1 more source

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]

open access: yes, 2009
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Altman   +74 more
core   +1 more source

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist [PDF]

open access: bronze, 1997
Theodore F. Reiss   +7 more
openalex   +1 more source

Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis

open access: yesAllergology International, 2008
Background: Secretion of nasal discharge was enhanced and airway-resistance in the nasal cavity was augmented, resulting in nasal congestion, when leukotrienes were administered to the nasal mucosa.
Kimihiro Okubo, Kohtaro Baba
doaj   +1 more source

Montelukast and Churg-Strauss syndrome [PDF]

open access: bronze, 2000
V. Villena   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy